Acurx Pharmaceuticals, Inc. (ACXP) SEC Filings https://ir.acurxpharma.com/section-16-filings/rss Acurx Pharmaceuticals, Inc. (ACXP) - Section 16 Filings en-us https://d1io3yog0oux5.cloudfront.net/_54f3e0bf8d6456169cd25706f74b6503/acurxpharma/logo.png Acurx Pharmaceuticals, Inc. Logo https://ir.acurxpharma.com Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-353-0001104659-25-010181 Thu, 06 Feb 25 17:48:20 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-353-0001104659-25-010181 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-352-0001104659-25-010180 Thu, 06 Feb 25 17:47:19 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-352-0001104659-25-010180 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-351-0001104659-25-010179 Thu, 06 Feb 25 17:46:07 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-351-0001104659-25-010179 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-345-0001104659-25-002054 Wed, 08 Jan 25 16:32:56 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-345-0001104659-25-002054 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-344-0001104659-25-002053 Wed, 08 Jan 25 16:32:21 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-344-0001104659-25-002053 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-343-0001104659-25-002052 Wed, 08 Jan 25 16:32:07 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-343-0001104659-25-002052 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-342-0001104659-25-002051 Wed, 08 Jan 25 16:31:54 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-342-0001104659-25-002051 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-341-0001104659-25-002050 Wed, 08 Jan 25 16:31:49 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-341-0001104659-25-002050 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-340-0001104659-25-002046 Wed, 08 Jan 25 16:30:39 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-340-0001104659-25-002046 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-317-0001104659-24-072815 Tue, 18 Jun 24 16:16:22 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-317-0001104659-24-072815